GKardia is a medical device and consulting company founded at the end of 2022 from our Founder, Gregory Krinos who after spending more than 20 years in Multinational Medical Devices companies in high level executive positions, has decided to build an organization with a unique mission to bring in SouthEastern Europe some of the most innovative and clinically proven therapies and products for the optimal patient care focusing mainly in CardioVascular sector.

3D Life is a start-up 3D printing-modeling company for medical applications based in Athens, Greece, with the vision to become one of the most admired companies in 3D printing optimizing Personalized Therapies in Healthcare and improving the quality of life for patients worldwide. More specifically, 3D Life focuses in designing and providing exact replica of patient’s organs that represent basic or very complex health problems for preoperative planning and intraoperative guides. Apart from personalized surgery these 3D printed models can serve patient education, learner education and surgical simulation purposes. In the area of R&D we are interested in building 3D printed medical devices as well as collaborating with major institutions and KOLs in the area of Bioprinting in the near future. Our company has also created the first in Europe and second in the world 3D Anatomic Heart Library (www.3dlife.gr/categories.php) which is expected to be developed in a multispecialty 3D Anatomic Library in the near future .

Pleioflow is a medical device company with disruptive technology in the field of flow assist devices. The Pleioflow devices are probably able to augment blood flow into, and salvage critical organs, in the clinical applications of Cardiac Arrest, Severe Heart Failure, Stroke, Diabetes and low Cardiac Output Acute Kidney Injury(AKI). Pleioflow was founded in the UK in 2018, after its proprietary technology was granted a Utility Patent with full Freedom to operate in the EU and USA.(www.pleioflow.com)

Full P&L responsibility for 3 countries in the SEE region.

Full P&L responsibility for 10 countries in the region(GRE,CYP,MAL,BUL,ROM,HUN,SLOV,CZE,POL,ALB).The position reports to VP Country Operations

Project on Sales Effectiveness methodology across European selling teams.Partially completed up to 2008.Full P&L and general management responsibility for Greece and Cyprus.The position reported to President Europe

Full P&L and Operation Responsibility for 9 countries in the region.(GRE,CYP,MAL,BUL,ROM,HUN,SLOV,CZE,POL).

General Management including legal entity introduction in GREECE

Responsible for the Strategic development,Profitability and Growth of Cardiovascular Group that was named Edwards Lifesciences following a spin off in the year 2000 worldwide